KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Non Operating Income (2017 - 2021)

LifeMD filings provide 3 years of Non Operating Income readings, the most recent being $2.6 million for Q4 2021.

  • On a quarterly basis, Non Operating Income fell 71.04% to $2.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$52000.0, a 100.67% decrease, with the full-year FY2024 number at $37000.0, down 47.89% from a year prior.
  • Non Operating Income hit $2.6 million in Q4 2021 for LifeMD, up from -$1.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $9.1 million in Q4 2020 to a low of -$1.8 million in Q3 2021.
  • Median Non Operating Income over the past 3 years was -$334154.5 (2017), compared with a mean of $676617.0.
  • The widest YoY moves for Non Operating Income: up 105.73% in 2021, down 526.86% in 2021.
  • LifeMD's Non Operating Income stood at -$569617.0 in 2017, then surged by 1693.7% to $9.1 million in 2020, then crashed by 71.04% to $2.6 million in 2021.
  • The last three reported values for Non Operating Income were $2.6 million (Q4 2021), -$1.8 million (Q3 2021), and -$901910.0 (Q2 2021) per Business Quant data.